bicuculline has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abercrombie, ED; Callahan, JW; Farrar, AM | 1 |
| Bartholini, G | 1 |
2 other study(ies) available for bicuculline and Huntington Disease
| Article | Year |
|---|---|
Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bicuculline; Cholinergic Neurons; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Excitatory Postsynaptic Potentials; GABA-A Receptor Antagonists; Humans; Huntingtin Protein; Huntington Disease; Inhibitory Postsynaptic Potentials; Interneurons; Mice; Mice, Transgenic; Motor Skills; Nerve Degeneration; Nerve Tissue Proteins; Neural Inhibition; Nuclear Proteins; Synaptic Transmission | 2011 |
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Topics: 4-Aminobutyrate Transaminase; Basal Ganglia Diseases; Bicuculline; Dopamine; Dyskinesia, Drug-Induced; Epilepsy; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Limbic System; Neural Pathways; Neurons; Neurotransmitter Agents; Parkinson Disease; Psychopharmacology | 1979 |